Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation TCT 2016

MATRIX Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Frederick Feit

October 31, 2016

Presentation TCT 2016

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Presenter: Sunil V. Rao, Harvey D. White, Salvatore Brugaletta

October 31, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

Presentation TCT 2015

MATRIX Trial Recap: Interaction Between Access Site and Antithrombin Choice in ACS

Presenter: Carlo Briguori, Roxana Mehran

October 15, 2015

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

Presentation TCT 2015

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Statistical Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Stuart J. Pocock

October 12, 2015

Presentation TCT 2015

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Clinical/Trialist Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Gregg W. Stone

October 12, 2015

News Conference News TCT 2015

Despite Setbacks, Research Into Myocardial Salvage Continues

October 12, 2015

News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Conference News

Preclinical Results Promising for Combo Stent

November 08, 2011

News Conference News

Ongoing Trials Explore Potential Benefits of Transradial PCI

November 08, 2011

Advertisement

MATRIX Critique: Pros and Cons

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

MATRIX Trial Recap: Interaction Between Access Site and Antithrombin Choice in ACS

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Statistical Perspective

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Clinical/Trialist Perspective

Despite Setbacks, Research Into Myocardial Salvage Continues

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

Two New SES Show Improvement Over First-Generation Stents

Preclinical Results Promising for Combo Stent

Ongoing Trials Explore Potential Benefits of Transradial PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content